Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HCA Healthcare (HCA)

HCA Healthcare Reports Third Quarter 2026 Results and Updates Full-Year Guidance

Mixed Impact 4 of 5 earnings

HCA Healthcare reported third quarter 2026 revenue of $19.849 billion and net income of $1.579 billion, alongside an updated full-year operating forecast in the upper half of its previously issued ranges. The company experienced an unfavorable payer mix shift due to increased uninsured volume, which negatively impacted pre-tax income by approximately $400 million.

Key points

  • Revenues increased 3.6 percent to $19.849 billion in the third quarter of 2026.
  • Net income attributable to HCA Healthcare, Inc. declined 3.9 percent to $1.579 billion.
  • The Board of Directors declared a quarterly cash dividend of $0.78 per share payable on December 29, 2026.
  • The company repurchased 7.230 million shares of its common stock at a cost of $2.970 billion during the third quarter.

The filing

CompanyHCA Healthcare (HCA)
Form8-K, current report
Filed with the SECOct 27, 2026, 7:17 AM ET
Accession number0001193125-26-432665

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Oct 29, 2026, 3:00 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.